Enhanced nerve growth factor expression by mast cells does not differ significantly between idiopathic and allergic rhinitis

Abstract Background The role of neurotrophins in allergic rhinitis (AR) has been well studied, but it has not been evaluated in idiopathic rhinitis (IR). Objective We aimed to evaluate the nasal β-nerve growth factor (β-NGF) expressions of mast cells in patients with AR and IR. Methods Seventeen pat...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Annals of allergy, asthma, & immunology asthma, & immunology, 2012-06, Vol.108 (6), p.396-401
Hauptverfasser: Gelincik, Aslı, MD, Aydın, Filiz, MD, Özerman, Bilge, MD, Ergüven, Mine, MD, Aydın, Salih, MD, Bilir, Ayhan, MD, Genç, Sema, MD, Eroğlu, Hacer, MD, Çolakoğlu, Bahattin, MD, Erden, Sacide, MD, Büyüköztürk, Suna, MD
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 401
container_issue 6
container_start_page 396
container_title Annals of allergy, asthma, & immunology
container_volume 108
creator Gelincik, Aslı, MD
Aydın, Filiz, MD
Özerman, Bilge, MD
Ergüven, Mine, MD
Aydın, Salih, MD
Bilir, Ayhan, MD
Genç, Sema, MD
Eroğlu, Hacer, MD
Çolakoğlu, Bahattin, MD
Erden, Sacide, MD
Büyüköztürk, Suna, MD
description Abstract Background The role of neurotrophins in allergic rhinitis (AR) has been well studied, but it has not been evaluated in idiopathic rhinitis (IR). Objective We aimed to evaluate the nasal β-nerve growth factor (β-NGF) expressions of mast cells in patients with AR and IR. Methods Seventeen patients with house dust mites–induced persistent moderate/severe allergic rhinitis (mean age: 29.7 ± 11.96), 14 patients with idiopathic rhinitis (mean age, 29.3 ± 10.62), and 16 healthy controls (29.9 ± 11.57) were included in the study. Nasal biopsy specimens were taken from the posterior part of the inferior turbinate from all of the study subjects. Nasal β-nerve growth factor and its receptors, pan-neurotrophin receptor p75, and tyrosine kinase A (trkA) were assessed with an immunofluorescence assay. Mast cells were determined by both an immunofluorescence assay and immunohistochemistry as tryptase-positive cells. Results The β-NGF, trkA, and p75 receptor counts were significantly higher in AR and IR patients than in the control group ( P < .001, for each), but they were not different between AR and IR patients. Similarly, the ratio of β-NGF+ mast cells/total mast cells and the ratio of β-NGF+ mast cells/total β-NGF+ cells in AR and IR patients was found to be elevated when compared with the control group ( P < .001, P < .001, P < .001, and P = .046, respectively); furthermore, the 2 ratios were not statistically different between the 2 patient groups. Conclusion The increase in β-NGF–expressing mast cells does not differ between idiopathic and allergic rhinitis. Therefore, we propose that mast cells do play a role in the pathogenesis of IR as important as in that of AR.
doi_str_mv 10.1016/j.anai.2012.04.006
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1016676289</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S1081120612002645</els_id><sourcerecordid>1016676289</sourcerecordid><originalsourceid>FETCH-LOGICAL-c441t-df7a17a4734b8f359414a06b36805cce26b4df6c1fc948fba4c093793c85b66f3</originalsourceid><addsrcrecordid>eNp9kkuLFDEURgtRnHH0D7iQbAQ3VeZVqSoQQYbxAQMu1HVIpW6601YnbW56Zhr88ZOyWwUXLkISON9NcnKr6jmjDaNMvd40JhjfcMp4Q2VDqXpQnbNWyFpKoR6WNe1ZzThVZ9UTxA2llPVKPK7OOFdctQM7r35ehbUJFiYSIN0AWaV4m9fEGZtjInC3S4DoYyDjgWwNZmJhnpFMEZCEmMnknYNE0K-Cd96akOcDGSHfAgTiJx93Jq-9JSZMxMwzpFXZpLUPPnt8Wj1yZkZ4dpovqm_vr75efqyvP3_4dPnuurZSslxPrjOsM7ITcuydaAfJpKFqFKqnrbXA1SgnpyxzdpC9G420dBDdIGzfjko5cVG9OtbdpfhjD5j11uPyEBMg7lEvNlWneD8UlB9RmyJiAqd3yW9NOhToF6c3erGuF-uaSl2sl9CLU_39uIXpT-S35gK8PAEGrZldKso9_uUUpbxXvHBvjhwUGzcekkbrYfken8BmPUX__3u8_Sdu52K6nPgdDoCbuE-heNZMY8noL0t_LO1RBuVKtuIe5rW29A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1016676289</pqid></control><display><type>article</type><title>Enhanced nerve growth factor expression by mast cells does not differ significantly between idiopathic and allergic rhinitis</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Gelincik, Aslı, MD ; Aydın, Filiz, MD ; Özerman, Bilge, MD ; Ergüven, Mine, MD ; Aydın, Salih, MD ; Bilir, Ayhan, MD ; Genç, Sema, MD ; Eroğlu, Hacer, MD ; Çolakoğlu, Bahattin, MD ; Erden, Sacide, MD ; Büyüköztürk, Suna, MD</creator><creatorcontrib>Gelincik, Aslı, MD ; Aydın, Filiz, MD ; Özerman, Bilge, MD ; Ergüven, Mine, MD ; Aydın, Salih, MD ; Bilir, Ayhan, MD ; Genç, Sema, MD ; Eroğlu, Hacer, MD ; Çolakoğlu, Bahattin, MD ; Erden, Sacide, MD ; Büyüköztürk, Suna, MD</creatorcontrib><description>Abstract Background The role of neurotrophins in allergic rhinitis (AR) has been well studied, but it has not been evaluated in idiopathic rhinitis (IR). Objective We aimed to evaluate the nasal β-nerve growth factor (β-NGF) expressions of mast cells in patients with AR and IR. Methods Seventeen patients with house dust mites–induced persistent moderate/severe allergic rhinitis (mean age: 29.7 ± 11.96), 14 patients with idiopathic rhinitis (mean age, 29.3 ± 10.62), and 16 healthy controls (29.9 ± 11.57) were included in the study. Nasal biopsy specimens were taken from the posterior part of the inferior turbinate from all of the study subjects. Nasal β-nerve growth factor and its receptors, pan-neurotrophin receptor p75, and tyrosine kinase A (trkA) were assessed with an immunofluorescence assay. Mast cells were determined by both an immunofluorescence assay and immunohistochemistry as tryptase-positive cells. Results The β-NGF, trkA, and p75 receptor counts were significantly higher in AR and IR patients than in the control group ( P &lt; .001, for each), but they were not different between AR and IR patients. Similarly, the ratio of β-NGF+ mast cells/total mast cells and the ratio of β-NGF+ mast cells/total β-NGF+ cells in AR and IR patients was found to be elevated when compared with the control group ( P &lt; .001, P &lt; .001, P &lt; .001, and P = .046, respectively); furthermore, the 2 ratios were not statistically different between the 2 patient groups. Conclusion The increase in β-NGF–expressing mast cells does not differ between idiopathic and allergic rhinitis. Therefore, we propose that mast cells do play a role in the pathogenesis of IR as important as in that of AR.</description><identifier>ISSN: 1081-1206</identifier><identifier>EISSN: 1534-4436</identifier><identifier>DOI: 10.1016/j.anai.2012.04.006</identifier><identifier>PMID: 22626591</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject>Adolescent ; Adult ; Allergy and Immunology ; Biological and medical sciences ; Case-Control Studies ; Cell Count ; Dermatology ; Female ; Fundamental and applied biological sciences. Psychology ; Fundamental immunology ; Gene Expression ; Humans ; Male ; Mast Cells - cytology ; Mast Cells - immunology ; Mast Cells - metabolism ; Medical sciences ; Nasal Mucosa - immunology ; Nasal Mucosa - physiopathology ; Nerve Growth Factor - genetics ; Nerve Growth Factor - immunology ; Non tumoral diseases ; Otorhinolaryngology. Stomatology ; Receptor, Nerve Growth Factor - genetics ; Receptor, Nerve Growth Factor - immunology ; Receptor, trkA - genetics ; Receptor, trkA - immunology ; Rhinitis, Allergic, Perennial - genetics ; Rhinitis, Allergic, Perennial - immunology ; Rhinitis, Allergic, Perennial - physiopathology ; Rhinitis, Vasomotor - genetics ; Rhinitis, Vasomotor - immunology ; Rhinitis, Vasomotor - physiopathology ; Sarcoidosis. Granulomatous diseases of unproved etiology. Connective tissue diseases. Elastic tissue diseases. Vasculitis ; Turkey ; Upper respiratory tract, upper alimentary tract, paranasal sinuses, salivary glands: diseases, semeiology</subject><ispartof>Annals of allergy, asthma, &amp; immunology, 2012-06, Vol.108 (6), p.396-401</ispartof><rights>American College of Allergy, Asthma &amp; Immunology</rights><rights>2012 American College of Allergy, Asthma &amp; Immunology</rights><rights>2015 INIST-CNRS</rights><rights>Copyright © 2012 American College of Allergy, Asthma &amp; Immunology. Published by Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c441t-df7a17a4734b8f359414a06b36805cce26b4df6c1fc948fba4c093793c85b66f3</citedby><cites>FETCH-LOGICAL-c441t-df7a17a4734b8f359414a06b36805cce26b4df6c1fc948fba4c093793c85b66f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.anai.2012.04.006$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=26002862$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22626591$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gelincik, Aslı, MD</creatorcontrib><creatorcontrib>Aydın, Filiz, MD</creatorcontrib><creatorcontrib>Özerman, Bilge, MD</creatorcontrib><creatorcontrib>Ergüven, Mine, MD</creatorcontrib><creatorcontrib>Aydın, Salih, MD</creatorcontrib><creatorcontrib>Bilir, Ayhan, MD</creatorcontrib><creatorcontrib>Genç, Sema, MD</creatorcontrib><creatorcontrib>Eroğlu, Hacer, MD</creatorcontrib><creatorcontrib>Çolakoğlu, Bahattin, MD</creatorcontrib><creatorcontrib>Erden, Sacide, MD</creatorcontrib><creatorcontrib>Büyüköztürk, Suna, MD</creatorcontrib><title>Enhanced nerve growth factor expression by mast cells does not differ significantly between idiopathic and allergic rhinitis</title><title>Annals of allergy, asthma, &amp; immunology</title><addtitle>Ann Allergy Asthma Immunol</addtitle><description>Abstract Background The role of neurotrophins in allergic rhinitis (AR) has been well studied, but it has not been evaluated in idiopathic rhinitis (IR). Objective We aimed to evaluate the nasal β-nerve growth factor (β-NGF) expressions of mast cells in patients with AR and IR. Methods Seventeen patients with house dust mites–induced persistent moderate/severe allergic rhinitis (mean age: 29.7 ± 11.96), 14 patients with idiopathic rhinitis (mean age, 29.3 ± 10.62), and 16 healthy controls (29.9 ± 11.57) were included in the study. Nasal biopsy specimens were taken from the posterior part of the inferior turbinate from all of the study subjects. Nasal β-nerve growth factor and its receptors, pan-neurotrophin receptor p75, and tyrosine kinase A (trkA) were assessed with an immunofluorescence assay. Mast cells were determined by both an immunofluorescence assay and immunohistochemistry as tryptase-positive cells. Results The β-NGF, trkA, and p75 receptor counts were significantly higher in AR and IR patients than in the control group ( P &lt; .001, for each), but they were not different between AR and IR patients. Similarly, the ratio of β-NGF+ mast cells/total mast cells and the ratio of β-NGF+ mast cells/total β-NGF+ cells in AR and IR patients was found to be elevated when compared with the control group ( P &lt; .001, P &lt; .001, P &lt; .001, and P = .046, respectively); furthermore, the 2 ratios were not statistically different between the 2 patient groups. Conclusion The increase in β-NGF–expressing mast cells does not differ between idiopathic and allergic rhinitis. Therefore, we propose that mast cells do play a role in the pathogenesis of IR as important as in that of AR.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Allergy and Immunology</subject><subject>Biological and medical sciences</subject><subject>Case-Control Studies</subject><subject>Cell Count</subject><subject>Dermatology</subject><subject>Female</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Fundamental immunology</subject><subject>Gene Expression</subject><subject>Humans</subject><subject>Male</subject><subject>Mast Cells - cytology</subject><subject>Mast Cells - immunology</subject><subject>Mast Cells - metabolism</subject><subject>Medical sciences</subject><subject>Nasal Mucosa - immunology</subject><subject>Nasal Mucosa - physiopathology</subject><subject>Nerve Growth Factor - genetics</subject><subject>Nerve Growth Factor - immunology</subject><subject>Non tumoral diseases</subject><subject>Otorhinolaryngology. Stomatology</subject><subject>Receptor, Nerve Growth Factor - genetics</subject><subject>Receptor, Nerve Growth Factor - immunology</subject><subject>Receptor, trkA - genetics</subject><subject>Receptor, trkA - immunology</subject><subject>Rhinitis, Allergic, Perennial - genetics</subject><subject>Rhinitis, Allergic, Perennial - immunology</subject><subject>Rhinitis, Allergic, Perennial - physiopathology</subject><subject>Rhinitis, Vasomotor - genetics</subject><subject>Rhinitis, Vasomotor - immunology</subject><subject>Rhinitis, Vasomotor - physiopathology</subject><subject>Sarcoidosis. Granulomatous diseases of unproved etiology. Connective tissue diseases. Elastic tissue diseases. Vasculitis</subject><subject>Turkey</subject><subject>Upper respiratory tract, upper alimentary tract, paranasal sinuses, salivary glands: diseases, semeiology</subject><issn>1081-1206</issn><issn>1534-4436</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kkuLFDEURgtRnHH0D7iQbAQ3VeZVqSoQQYbxAQMu1HVIpW6601YnbW56Zhr88ZOyWwUXLkISON9NcnKr6jmjDaNMvd40JhjfcMp4Q2VDqXpQnbNWyFpKoR6WNe1ZzThVZ9UTxA2llPVKPK7OOFdctQM7r35ehbUJFiYSIN0AWaV4m9fEGZtjInC3S4DoYyDjgWwNZmJhnpFMEZCEmMnknYNE0K-Cd96akOcDGSHfAgTiJx93Jq-9JSZMxMwzpFXZpLUPPnt8Wj1yZkZ4dpovqm_vr75efqyvP3_4dPnuurZSslxPrjOsM7ITcuydaAfJpKFqFKqnrbXA1SgnpyxzdpC9G420dBDdIGzfjko5cVG9OtbdpfhjD5j11uPyEBMg7lEvNlWneD8UlB9RmyJiAqd3yW9NOhToF6c3erGuF-uaSl2sl9CLU_39uIXpT-S35gK8PAEGrZldKso9_uUUpbxXvHBvjhwUGzcekkbrYfken8BmPUX__3u8_Sdu52K6nPgdDoCbuE-heNZMY8noL0t_LO1RBuVKtuIe5rW29A</recordid><startdate>20120601</startdate><enddate>20120601</enddate><creator>Gelincik, Aslı, MD</creator><creator>Aydın, Filiz, MD</creator><creator>Özerman, Bilge, MD</creator><creator>Ergüven, Mine, MD</creator><creator>Aydın, Salih, MD</creator><creator>Bilir, Ayhan, MD</creator><creator>Genç, Sema, MD</creator><creator>Eroğlu, Hacer, MD</creator><creator>Çolakoğlu, Bahattin, MD</creator><creator>Erden, Sacide, MD</creator><creator>Büyüköztürk, Suna, MD</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20120601</creationdate><title>Enhanced nerve growth factor expression by mast cells does not differ significantly between idiopathic and allergic rhinitis</title><author>Gelincik, Aslı, MD ; Aydın, Filiz, MD ; Özerman, Bilge, MD ; Ergüven, Mine, MD ; Aydın, Salih, MD ; Bilir, Ayhan, MD ; Genç, Sema, MD ; Eroğlu, Hacer, MD ; Çolakoğlu, Bahattin, MD ; Erden, Sacide, MD ; Büyüköztürk, Suna, MD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c441t-df7a17a4734b8f359414a06b36805cce26b4df6c1fc948fba4c093793c85b66f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Allergy and Immunology</topic><topic>Biological and medical sciences</topic><topic>Case-Control Studies</topic><topic>Cell Count</topic><topic>Dermatology</topic><topic>Female</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Fundamental immunology</topic><topic>Gene Expression</topic><topic>Humans</topic><topic>Male</topic><topic>Mast Cells - cytology</topic><topic>Mast Cells - immunology</topic><topic>Mast Cells - metabolism</topic><topic>Medical sciences</topic><topic>Nasal Mucosa - immunology</topic><topic>Nasal Mucosa - physiopathology</topic><topic>Nerve Growth Factor - genetics</topic><topic>Nerve Growth Factor - immunology</topic><topic>Non tumoral diseases</topic><topic>Otorhinolaryngology. Stomatology</topic><topic>Receptor, Nerve Growth Factor - genetics</topic><topic>Receptor, Nerve Growth Factor - immunology</topic><topic>Receptor, trkA - genetics</topic><topic>Receptor, trkA - immunology</topic><topic>Rhinitis, Allergic, Perennial - genetics</topic><topic>Rhinitis, Allergic, Perennial - immunology</topic><topic>Rhinitis, Allergic, Perennial - physiopathology</topic><topic>Rhinitis, Vasomotor - genetics</topic><topic>Rhinitis, Vasomotor - immunology</topic><topic>Rhinitis, Vasomotor - physiopathology</topic><topic>Sarcoidosis. Granulomatous diseases of unproved etiology. Connective tissue diseases. Elastic tissue diseases. Vasculitis</topic><topic>Turkey</topic><topic>Upper respiratory tract, upper alimentary tract, paranasal sinuses, salivary glands: diseases, semeiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gelincik, Aslı, MD</creatorcontrib><creatorcontrib>Aydın, Filiz, MD</creatorcontrib><creatorcontrib>Özerman, Bilge, MD</creatorcontrib><creatorcontrib>Ergüven, Mine, MD</creatorcontrib><creatorcontrib>Aydın, Salih, MD</creatorcontrib><creatorcontrib>Bilir, Ayhan, MD</creatorcontrib><creatorcontrib>Genç, Sema, MD</creatorcontrib><creatorcontrib>Eroğlu, Hacer, MD</creatorcontrib><creatorcontrib>Çolakoğlu, Bahattin, MD</creatorcontrib><creatorcontrib>Erden, Sacide, MD</creatorcontrib><creatorcontrib>Büyüköztürk, Suna, MD</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Annals of allergy, asthma, &amp; immunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gelincik, Aslı, MD</au><au>Aydın, Filiz, MD</au><au>Özerman, Bilge, MD</au><au>Ergüven, Mine, MD</au><au>Aydın, Salih, MD</au><au>Bilir, Ayhan, MD</au><au>Genç, Sema, MD</au><au>Eroğlu, Hacer, MD</au><au>Çolakoğlu, Bahattin, MD</au><au>Erden, Sacide, MD</au><au>Büyüköztürk, Suna, MD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Enhanced nerve growth factor expression by mast cells does not differ significantly between idiopathic and allergic rhinitis</atitle><jtitle>Annals of allergy, asthma, &amp; immunology</jtitle><addtitle>Ann Allergy Asthma Immunol</addtitle><date>2012-06-01</date><risdate>2012</risdate><volume>108</volume><issue>6</issue><spage>396</spage><epage>401</epage><pages>396-401</pages><issn>1081-1206</issn><eissn>1534-4436</eissn><abstract>Abstract Background The role of neurotrophins in allergic rhinitis (AR) has been well studied, but it has not been evaluated in idiopathic rhinitis (IR). Objective We aimed to evaluate the nasal β-nerve growth factor (β-NGF) expressions of mast cells in patients with AR and IR. Methods Seventeen patients with house dust mites–induced persistent moderate/severe allergic rhinitis (mean age: 29.7 ± 11.96), 14 patients with idiopathic rhinitis (mean age, 29.3 ± 10.62), and 16 healthy controls (29.9 ± 11.57) were included in the study. Nasal biopsy specimens were taken from the posterior part of the inferior turbinate from all of the study subjects. Nasal β-nerve growth factor and its receptors, pan-neurotrophin receptor p75, and tyrosine kinase A (trkA) were assessed with an immunofluorescence assay. Mast cells were determined by both an immunofluorescence assay and immunohistochemistry as tryptase-positive cells. Results The β-NGF, trkA, and p75 receptor counts were significantly higher in AR and IR patients than in the control group ( P &lt; .001, for each), but they were not different between AR and IR patients. Similarly, the ratio of β-NGF+ mast cells/total mast cells and the ratio of β-NGF+ mast cells/total β-NGF+ cells in AR and IR patients was found to be elevated when compared with the control group ( P &lt; .001, P &lt; .001, P &lt; .001, and P = .046, respectively); furthermore, the 2 ratios were not statistically different between the 2 patient groups. Conclusion The increase in β-NGF–expressing mast cells does not differ between idiopathic and allergic rhinitis. Therefore, we propose that mast cells do play a role in the pathogenesis of IR as important as in that of AR.</abstract><cop>New York, NY</cop><pub>Elsevier Inc</pub><pmid>22626591</pmid><doi>10.1016/j.anai.2012.04.006</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1081-1206
ispartof Annals of allergy, asthma, & immunology, 2012-06, Vol.108 (6), p.396-401
issn 1081-1206
1534-4436
language eng
recordid cdi_proquest_miscellaneous_1016676289
source MEDLINE; Elsevier ScienceDirect Journals Complete
subjects Adolescent
Adult
Allergy and Immunology
Biological and medical sciences
Case-Control Studies
Cell Count
Dermatology
Female
Fundamental and applied biological sciences. Psychology
Fundamental immunology
Gene Expression
Humans
Male
Mast Cells - cytology
Mast Cells - immunology
Mast Cells - metabolism
Medical sciences
Nasal Mucosa - immunology
Nasal Mucosa - physiopathology
Nerve Growth Factor - genetics
Nerve Growth Factor - immunology
Non tumoral diseases
Otorhinolaryngology. Stomatology
Receptor, Nerve Growth Factor - genetics
Receptor, Nerve Growth Factor - immunology
Receptor, trkA - genetics
Receptor, trkA - immunology
Rhinitis, Allergic, Perennial - genetics
Rhinitis, Allergic, Perennial - immunology
Rhinitis, Allergic, Perennial - physiopathology
Rhinitis, Vasomotor - genetics
Rhinitis, Vasomotor - immunology
Rhinitis, Vasomotor - physiopathology
Sarcoidosis. Granulomatous diseases of unproved etiology. Connective tissue diseases. Elastic tissue diseases. Vasculitis
Turkey
Upper respiratory tract, upper alimentary tract, paranasal sinuses, salivary glands: diseases, semeiology
title Enhanced nerve growth factor expression by mast cells does not differ significantly between idiopathic and allergic rhinitis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T06%3A47%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Enhanced%20nerve%20growth%20factor%20expression%20by%20mast%20cells%20does%20not%20differ%20significantly%20between%20idiopathic%20and%20allergic%20rhinitis&rft.jtitle=Annals%20of%20allergy,%20asthma,%20&%20immunology&rft.au=Gelincik,%20Asl%C4%B1,%20MD&rft.date=2012-06-01&rft.volume=108&rft.issue=6&rft.spage=396&rft.epage=401&rft.pages=396-401&rft.issn=1081-1206&rft.eissn=1534-4436&rft_id=info:doi/10.1016/j.anai.2012.04.006&rft_dat=%3Cproquest_cross%3E1016676289%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1016676289&rft_id=info:pmid/22626591&rft_els_id=1_s2_0_S1081120612002645&rfr_iscdi=true